ERP44 Is Associated With Poor Prognosis and Promotes Proliferation and Temozolomide Resistance in Lower-grade Glioma Unknown authors 2026 · Cancer Genomics & Proteomics · Vol 23, pp. 914 - 933 · 0 citations · 23 references DOI Semantic Scholar Save View source Cite Copy APA Copied ✓ Copy MLA Copied ✓ Copy BibTeX Copied ✓ Share